Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,567,617
+$49,737 QoQ
Shares Held
4,329
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1,415
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. AMGN ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
This page
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,567,617 | 4,329 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,517,880 | 4,314 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,406,451 | 4,297 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,142,063 | 4,047 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,110,138 | 3,976 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,192,613 | 3,828 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $996,948 | 3,825 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,153,189 | 3,579 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,097,636 | 3,513 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $914,941 | 3,218 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $936,929 | 3,253 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $874,276 | 3,253 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $722,231 | 3,253 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $786,412 | 3,253 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $868,025 | 3,305 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $756,893 | 3,358 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $816,758 | 3,357 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $798,731 | 3,303 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $751,849 | 3,342 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $752,143 | 3,537 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $862,143 | 3,537 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $867,600 | 3,487 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $525,827 | 2,287 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $592,955 | 2,333 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $542,242 | 2,299 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $430,193 | 2,122 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||